Zentalis Pharmaceuticals, Inc.
$336.07M- Market cap
- $287.40M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.98x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.26x
$4.01Latest market snapshot
Implied fair value · at LHX's multiple
$2.1147.5% below market
0.94 ZNTL revenue / share×2.24x LHX P/S=$2.11
Market $4.01Implied $2.11
LHX · current priceP/S 2.24x
$256.49Latest market snapshot
Implied fair value · at ZNTL's multiple
$488.1490.3% above market
114.52 LHX revenue / share×4.26x ZNTL P/S=$488.14
Market $256.49Implied $488.14